Please ensure Javascript is enabled for purposes of website accessibility

Why Synopsys Stock Gained 15% in August

By Demitri Kalogeropoulos – Sep 4, 2021 at 8:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company posted strong Q3 earnings and hinted at a major upgrade to its long-term outlook coming in Q4.

What happened

Synopsys (SNPS -2.70%) shareholders beat a rallying market last month. The stock rose 15% in August compared to 3% spike in the S&P 500, according to data provided by S&P Global Market Intelligence. The semiconductor tech giant reported strong earnings and issued a bullish outlook for both 2021 and over the long term.

So what

Sales trends were robust in the fiscal third quarter, with revenue rising 10% to just under $1.1 billion. That success put Synopsys on a growth and earnings trajectory that management believes is meaningfully better than it had previously estimated. "The market is not only strong," co-CEO Aart de Gues said in the conference call, "it is transforming in a way that is very positive for Synopsys."

An engineer working on a computer chip.

Image source: Getty Images.

Executives say demand for advanced semiconductor chips is rising and should continue expanding thanks to major tailwinds including data storage, transmittal, and processing.

Now what

Synopsys raised its 2021 outlook, which helps explain why shares are beating the market so far this year. But management also predicted that the need for semiconductor chips is already stretching into future years. More customers are committing to multiyear contracts, which is great news in this cyclical industry.

Next up, look for the company to issue an updated long-term outlook in November that likely predicts double-digit sales growth through 2023, along with steadily rising profit margin. Hitting those ambitious targets would mean further solid returns for shareholders.

Demitri Kalogeropoulos has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Synopsys. The Motley Fool has a disclosure policy.

Stocks Mentioned

Synopsys Stock Quote
$348.17 (-2.70%) $-9.67

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.